Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 24, 2008 1:26:33 PM CDT

Learn about Newser Points »

Stories related to: Schering Plough

Stories

6 Stories

  • July 2008

    • Pharma, Tech Kill Early Gains

      newser  |  MarketWatch  |  Jul 21, 08 3:40 PM CDT

      Pharma, Tech Kill Early Gains

      The markets failed to hold on to early-session gains today as oil rose above $131 per barrel and the overall economic outlook remained downcast, MarketWatch reports. The Dow lost 29.23 points to close at 11,467.34, the Nasdaq fell 3.25 to 2,279.53, and the S&P 500 dropped just 0.68, settling at 1,260.00. More »

      Tags

      Google  • S&P 500  • Nasdaq  • Dow Jones Industrial Average  • Bank of America  • pharmaceutical companies  • Merck  • Schering Plough

  • May 2008
  • April 2008

    • Doc: Merck Fudged Minutes of Meeting

      newser  |  Bloomberg  |  Apr 12, 08 9:33 AM CDT

      Doc: Merck Fudged Minutes of Meeting

      Merck's "minutes" of a meeting of heart doctors discussing cholesterol drug Vytorin were created a month after the meeting and distorted the viewpoints of the experts, one panel member changes. The drug company submitted the document to congressional investigators probing its two-year delay in releasing a report saying the drug didn't work any better than a much cheaper generic one, Bloomberg reports. More »

      Tags

      pharmaceutical companies  • Merck  • drug companies  • clinical trials  • cholesterol lowering drug  • Schering Plough  • Vytorin

    • Firms Hid Bad News on Heart Drugs 2 Years: Doc

      newser  |  New York Times  |  Apr 1, 08 10:49 AM CDT

      Firms Hid Bad News on Heart Drugs 2 Years: Doc

      A scientist hired by two drug companies to conduct trials of cholesterol-lowering drugs accused the firms of deliberately delaying release of the results, the New York Times reports. The results for the Vytorin and Zetia trials—which showed the drugs don't work to reduce plaque in arteries—were not released until almost two years after the medical trials wrapped up.  More »

      Tags

      Merck  • cholesterol  • drug companies  • clinical trials  • cholesterol lowering drug  • Schering Plough  • Vytorin  • Zetia

  • March 2008
  • January 2008

    • Generic Beats Pricey Pill on Cholesterol

      newser  |  Bloomberg  |  Jan 14, 08 5:42 PM CST

      Generic Beats Pricey Pill on Cholesterol

      A cheap generic drug cuts arterial buildup as well as a pricey pill and may threaten the growth of two drug companies, Bloomberg reports. Vytorin is produced by Merck & Co. and Schering-Plough Corp. and costs $2.84 per dose; simvastin, a generic, costs 3 cents a pill and works just as well, according to a new study. Stocks fell for both companies after the news broke today. More »

      Tags

      heart attack  • Merck  • cholesterol  • Schering Plough  • Vytorin  • LDL  • Zetia

6 Stories

Today's Most Popular

Loading...

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »